| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,484 | 11,045 | 10,214 | 11,824 | | Cost of Revenue | 6,876 | 7,913 | 22,080 | (5,206) | | | Gross Profit | 4,608 | 3,132 | (11,866) | 17,030 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,881 | 440 | (13,747) | 14,589 | | Non Recurring |
-
|
-
|
-
| 684 | | Others | 1,669 | 1,686 | 1,692 | 1,703 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,058 | 1,006 | 189 | 54 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,245) | 4,470 | (1,033) | 830 | | Earnings Before Interest And Taxes | (187) | 5,572 | (844) | 884 | | Interest Expense | 1,889 | 1,828 | 1,813 | 2,220 | | Income Before Tax | (2,076) | 3,744 | (2,657) | (1,336) | | Income Tax Expense | (707) | 1,519 | (691) | (276) | | Minority Interest | 396 | (543) | 640 | 414 | | | | Net Income From Continuing Ops | (1,369) | 1,586 | (1,326) | (646) | | | Non-recurring Events | | Discontinued Operations | 42 | 29 | 66 | 31 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (931) | 1,615 | (1,260) | (615) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($931) | $1,615 | ($1,260) | ($615) |
|
0.26% Nasdaq 0.00%
Income Statement
